{"gene":"CTC1","run_date":"2026-06-09T22:57:19","timeline":{"discoveries":[{"year":2009,"finding":"Mammalian CTC1 forms an RPA-like trimeric complex with STN1 and TEN1 (CST complex) that binds single-stranded DNA with high affinity in a sequence-independent manner and associates with a fraction of telomeres throughout the cell cycle. STN1 knockdown caused significant increases in single-stranded G-strand telomeric DNA, indicating a role in DNA metabolism at telomeres.","method":"Protein isolation, ssDNA binding assays, immunofluorescence/colocalization, knockdown with telomere analysis","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal characterization with multiple orthogonal methods (ssDNA binding, cell fractionation, IF colocalization, knockdown phenotype); foundational study replicated by multiple subsequent labs","pmids":["19854130"],"is_preprint":false},{"year":2011,"finding":"Xenopus CST (xCST) complex is involved in priming DNA synthesis on single-stranded DNA templates via regulation of DNA polymerase α-primase; immunodepletion of xStn1 blocked DNA synthesis on ssDNA template but not on pre-primed ssDNA, indicating CST acts at the priming step.","method":"Xenopus egg extract reconstitution, immunodepletion of xStn1, in vitro DNA replication assay on ssDNA templates","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution in Xenopus egg extract with immunodepletion and primed vs unprimed ssDNA controls, single lab but multiple orthogonal experiments","pmids":["22086929"],"is_preprint":false},{"year":2012,"finding":"CTC1 is a subunit of the α-accessory factor (AAF) complex that stimulates the activity of DNA polymerase-α primase. CTC1 mutations in Coats plus patients result in shortened telomeres and increased spontaneous γH2AX-positive cells.","method":"Patient mutation analysis, telomere length measurement, γH2AX immunostaining in patient-derived cell lines","journal":"Nature genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional cellular readouts in patient-derived lines with two orthogonal methods, single study","pmids":["22267198"],"is_preprint":false},{"year":2012,"finding":"Conditional deletion of CTC1 in mice leads to ATR-dependent G2/M checkpoint activation, global cellular proliferative defects, bone marrow failure, and catastrophic telomere loss. CTC1 facilitates telomere replication by promoting efficient restart of stalled replication forks, and its deletion causes increased loss of leading C-strand telomeres and accumulation of excessive ssDNA telomere sequences. CTC1 is not required for telomere capping.","method":"Conditional mouse knockout (Cre-lox), flow cytometry, telomere FISH, BrdU incorporation, ATR pathway analysis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean conditional KO in mice with multiple orthogonal readouts (proliferation, checkpoint activation, telomere structure); findings consistent with subsequent independent studies","pmids":["22531781"],"is_preprint":false},{"year":2013,"finding":"Disease mutations in CTC1 disrupt: (1) CST complex formation with STN1/TEN1; (2) physical interaction with DNA polymerase α-primase; (3) telomeric ssDNA binding in vitro; (4) nuclear accumulation; and/or (5) telomere association in vivo. All mutations commonly lead to accumulation of internal single-stranded gaps of telomeric DNA, indicating telomere DNA replication defects. Some CTC1 mutations also unleash telomerase repression and telomere length control.","method":"Co-immunoprecipitation, in vitro ssDNA binding assays, immunofluorescence, telomere FISH, active-site/disease mutation analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal biochemical and cell biological methods in a single focused study; findings replicated by independent groups","pmids":["24115768"],"is_preprint":false},{"year":2013,"finding":"CTC1 frameshift mutations generate truncated or unstable protein products that cannot form a complex with STN1-TEN1 at telomeres, resulting in progressive telomere shortening and chromosome fusions. CTC1 missense mutations can form the CST complex at telomeres but may be repressed by frameshift mutants. CTC1 mutations promote telomere dysfunction by decreasing STN1 stability and reducing STN1's ability to interact with DNA Pol-α.","method":"Biochemical characterization of mutant proteins, Co-IP, telomere FISH, chromosomal fusion analysis in human cells","journal":"Aging cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical assays in a single lab with disease mutation panel; partially replicated by Chen et al. 2013","pmids":["23869908"],"is_preprint":false},{"year":2017,"finding":"Disruption of CTC1 in human cells results in elongation of the 3′ G-strand overhang, accumulation of RPA at telomeres, and telomeric DNA damage signaling. C-strand length decreases continuously following CTC1 disruption while G-strand initially grows (due to telomerase), indicating CST-mediated C-strand fill-in is essential for telomere length maintenance and that telomerase-mediated G-strand extension and CST-mediated C-strand fill-in are equally important.","method":"CTC1 disruption in human cells, telomere overhang assays, RPA ChIP, telomere length measurement over time","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean CTC1 disruption with multiple independent telomere structural readouts; findings replicated across multiple groups","pmids":["28334750"],"is_preprint":false},{"year":2017,"finding":"Human CST complex localizes to ALT-associated PML bodies (APBs) in ALT cancer cells. CST suppression in ALT cells induces telomere fragility, elevated telomeric DNA recombination, reduces C-circle and t-circle abundance, and causes multinucleation.","method":"IF colocalization in ALT cells, CST knockdown, C-circle assay, telomere FISH","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization experiments linked to functional consequences, multiple readouts, single lab","pmids":["28366536"],"is_preprint":false},{"year":2018,"finding":"Crystal structure of a central OB-fold domain of human CTC1 was determined. This domain does not directly contribute to substrate binding but affects full-length CTC1 localization to telomeres and STN1-TEN1 binding. Disease mutations R840W and V871M contribute to the fold of this domain. Deletion of this OB-fold domain leads to increased telomere length, frequency of internal single G-strands, and fragile telomeres.","method":"X-ray crystallography, in vitro binding assays, site-directed mutagenesis, telomere localization assays, telomere FISH","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure with mutagenesis validation and functional telomere assays, single lab with multiple orthogonal methods","pmids":["29228254"],"is_preprint":false},{"year":2018,"finding":"CTC1-STN1 interaction is required to repress telomerase activity. CTC1^L1142H mutation impairs CTC1-STN1 interaction, leading to telomerase-mediated telomere elongation. Impaired CTC1^L1142H:STN1 interaction with DNA Pol-α results in increased telomerase recruitment and further telomere elongation. CST binding to DNA Pol-α is required to fully repress telomerase activity. CST mutants that fail to interact with DNA Pol-α result in loss of C-strand maintenance and catastrophic telomere shortening.","method":"CRISPR/Cas9 knock-in of disease mutation, Co-IP, telomere length analysis, telomerase recruitment assay","journal":"Aging cell","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — CRISPR knock-in with multiple biochemical and functional readouts, mechanistically dissecting G-strand vs C-strand regulation; consistent with independent studies","pmids":["29774655"],"is_preprint":false},{"year":2018,"finding":"Pathogenic CTC1 missense and small deletion mutations induce spontaneous chromosome breakage and severe chromosome fragmentation elevated by replication stress, leading to global genome instabilities. These mutations abolish or reduce CST interaction with RAD51, disrupt RAD51 foci formation, and/or diminish binding to GC-rich genomic fragile sites. The aa 600-989 region of CTC1 contains a RAD51-interacting domain.","method":"Co-IP (CST-RAD51), RAD51 foci immunofluorescence, chromosome breakage analysis, fragile site FISH, disease mutation panel","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple mutant panel with Co-IP and chromosomal readouts, single lab, two orthogonal methods","pmids":["29481669"],"is_preprint":false},{"year":2018,"finding":"CTC1-STN1 limits telomerase action to prevent G-overhang overextension. CTC1-/- cells exhibit telomeric DNA damage and growth arrest due to overhang elongation. CTC1-STN1 retains ssDNA binding affinity but TEN1 stabilizes binding. CTC1-STN1 binding is sufficient to terminate telomerase action, but without TEN1 it cannot properly engage DNA polymerase α on the overhang for C-strand synthesis.","method":"CRISPR knockout of individual CST subunits (CTC1, TEN1), ssDNA binding assays, telomere overhang analysis, cell proliferation assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — individual subunit knockouts with biochemical and functional dissection; distinguishes CTC1-STN1 vs TEN1 roles with multiple readouts","pmids":["30026550"],"is_preprint":false},{"year":2020,"finding":"CTC1 knockout inhibits CHK1 phosphorylation following hydroxyurea-induced replication stress by causing decreased levels of the ATR activator TopBP1. CTC1 KO activates ATR locally at telomeres (leading to RPA and ATR autophosphorylation) but does not elicit a global checkpoint response through CHK1. ATR but not CHK1 or ATM is required for G2 arrest and RPA phosphorylation following CTC1 removal.","method":"Conditional CTC1 knockout, phospho-CHK1/RPA/ATR immunoblot, TopBP1 protein level analysis, ATR/CHK1/ATM inhibition epistasis","journal":"Cell cycle (Georgetown, Tex.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with epistasis analysis and multiple signaling readouts, single lab","pmids":["33269665"],"is_preprint":false},{"year":2023,"finding":"CTC1 OB-B domain is a key determinant of telomerase termination but not C-strand synthesis. CTC1-ΔB expression rescues C-strand fill-in and prevents telomeric DNA damage but causes progressive telomere elongation and accumulation of telomerase at telomeres. CTC1 OB-B domain mediates interaction with TPP1, and this CTC1-TPP1 interaction plays a key role in telomerase termination. OB-B point mutations weakening TPP1 association track with inability to limit telomerase action.","method":"CTC1 domain deletion/point mutant panel in CTC1-/- cells, Co-IP (CST-TPP1), telomere length analysis, telomerase ChIP, C-strand fill-in assays","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — structure-function dissection with multiple CTC1 mutants, reciprocal Co-IP, and functional rescue experiments; mechanistically comprehensive single study","pmids":["37021555"],"is_preprint":false},{"year":2025,"finding":"The CST complex suppresses DNA end resection by EXO1 and the BLM-DNA2 helicase-nuclease complex, controlling DSB repair pathway choice between end joining and homologous recombination. CST acts as a central 53BP1 axis component. BRCA1-BARD1 alleviates CST-imposed EXO1 blockade but has little effect on BLM-DNA2 restriction. CST mutants impaired for DNA binding or BLM-EXO1 interaction exhibit hyper-resection and render BRCA1-deficient cells resistant to PARP inhibitors.","method":"Epistasis genetics, resection assays, CST DNA-binding and protein interaction mutants, PARP inhibitor sensitivity in BRCA1-deficient cells, in vitro reconstitution of end resection","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — mechanistic dissection with multiple mutants, epistasis with BRCA1-BARD1, in vitro and in vivo resection assays, published in Science","pmids":["40403056"],"is_preprint":false},{"year":2025,"finding":"STN1 directly interacts with CTC1 and stabilizes CTC1 by preventing its TRIM32-mediated ubiquitination and proteasomal degradation. TRIM32 interacts with the OB-G domain of CTC1 near the STN1-interacting 'cleft' motif, and STN1 binding to this region competes with TRIM32 to protect CTC1 from degradation. TRIM32 and the CTC1/STN1 complex exert opposing effects on cellular proliferation.","method":"Co-IP (STN1-CTC1, TRIM32-CTC1), ubiquitination assays, proteasome inhibitor rescue, AlphaFold3 structural modeling, knockdown/overexpression proliferation assays","journal":"Aging cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP with functional ubiquitination assays and structural modeling; single lab, novel finding not yet replicated","pmids":["40923710"],"is_preprint":false}],"current_model":"CTC1 forms the heterotrimeric RPA-like CST complex (CTC1-STN1-TEN1) that binds ssDNA and functions at telomeres by: (1) promoting C-strand fill-in synthesis via stimulation of DNA polymerase α-primase; (2) terminating telomerase-mediated G-strand extension through its OB-B domain interaction with TPP1; (3) restarting stalled replication forks at telomeres; (4) suppressing DNA end resection at DSBs as a 53BP1 axis component to control repair pathway choice; CTC1 is stabilized by direct STN1 interaction which competes with TRIM32-mediated ubiquitination, and disease mutations in CTC1 disrupt complex formation, DNA pol-α interaction, ssDNA binding, nuclear localization, and/or telomere association, collectively causing telomere replication defects and global genome instability."},"narrative":{"mechanistic_narrative":"CTC1 is the largest subunit of the heterotrimeric, RPA-like CST complex (CTC1-STN1-TEN1) that binds single-stranded DNA with high, sequence-independent affinity and acts at telomeres to coordinate the completion of replication and the regulation of telomerase [PMID:19854130, PMID:30026550]. Mechanistically, CST stimulates DNA polymerase α-primase to prime and fill in the telomeric C-strand: it functions at the priming step on ssDNA templates [PMID:22086929], operates as the α-accessory factor that stimulates pol α-primase activity [PMID:22267198], and promotes restart of stalled replication forks during telomere replication, with loss causing C-strand depletion, excess G-strand ssDNA, ATR-dependent checkpoint activation, and catastrophic telomere loss [PMID:22531781, PMID:28334750]. CST balances this fill-in activity against telomerase: CTC1-STN1 binding terminates telomerase-mediated G-strand extension and prevents overhang overextension, while the CTC1 OB-B domain mediates a TPP1 interaction that is the key determinant of telomerase termination, separable from its C-strand synthesis role [PMID:30026550, PMID:37021555]. Beyond telomeres, CST acts as a central component of the 53BP1 axis at double-strand breaks, suppressing EXO1- and BLM-DNA2-mediated end resection to govern repair pathway choice, with BRCA1-BARD1 relieving the CST-imposed EXO1 blockade [PMID:40403056]. CST also localizes to ALT-associated PML bodies and restrains telomeric recombination in ALT cancer cells [PMID:28366536], and CTC1 interacts with RAD51 to protect GC-rich genomic fragile sites against replication-stress-induced breakage [PMID:29481669]. CTC1 stability is set by STN1, which binds near the OB-G cleft and competes with TRIM32-mediated ubiquitination and proteasomal degradation [PMID:40923710]. Pathogenic CTC1 mutations in Coats plus disrupt CST assembly, pol α-primase interaction, ssDNA binding, nuclear accumulation, and/or telomere association, producing internal telomeric ssDNA gaps, telomere shortening, chromosome fusions, and global genome instability [PMID:22267198, PMID:24115768, PMID:23869908].","teleology":[{"year":2009,"claim":"Established that mammalian CTC1 is not a standalone factor but a subunit of an RPA-like ssDNA-binding trimer (CST) acting at telomeres, defining the molecular entity to be studied.","evidence":"Protein isolation, ssDNA binding assays, IF colocalization, and STN1 knockdown with telomere analysis","pmids":["19854130"],"confidence":"High","gaps":["Did not define which enzymatic step CST controls","Fraction of telomeres bound and cell-cycle dependence not mechanistically explained"]},{"year":2011,"claim":"Placed CST at the priming step of DNA synthesis, showing it regulates DNA pol α-primase rather than elongation, the first mechanistic assignment of a catalytic function.","evidence":"Xenopus egg extract reconstitution with xStn1 immunodepletion and primed vs unprimed ssDNA controls","pmids":["22086929"],"confidence":"High","gaps":["Done in Xenopus extract, not human reconstitution","Direct physical contact between CTC1 and pol α not mapped here"]},{"year":2012,"claim":"Connected CTC1 to human disease and to pol α-primase stimulation, showing loss-of-function causes telomere shortening and DNA damage in patients.","evidence":"Coats plus patient mutation analysis, telomere length and γH2AX immunostaining in patient cells; biochemical identification as α-accessory factor","pmids":["22267198"],"confidence":"Medium","gaps":["Single study","Did not separate replication defect from telomerase dysregulation"]},{"year":2012,"claim":"Defined CTC1's in vivo role as facilitating telomere replication via stalled fork restart, distinct from telomere capping, and linked its loss to ATR checkpoint and bone marrow failure.","evidence":"Conditional mouse knockout with telomere FISH, BrdU incorporation, flow cytometry, ATR pathway analysis","pmids":["22531781"],"confidence":"High","gaps":["Mechanism of fork restart not biochemically reconstituted","Relationship between leading C-strand loss and pol α stimulation not resolved"]},{"year":2013,"claim":"Resolved how disease mutations act by mapping them to discrete molecular defects—complex assembly, pol α binding, ssDNA binding, nuclear localization, telomere association—unifying genotype with telomere replication failure.","evidence":"Co-IP, in vitro ssDNA binding, IF, telomere FISH across disease and active-site mutation panels in human cells","pmids":["24115768","23869908"],"confidence":"High","gaps":["Some mutations had pleiotropic effects, complicating one-to-one defect assignment","STN1 stability effects characterized only in part"]},{"year":2017,"claim":"Demonstrated that CST-mediated C-strand fill-in is as essential as telomerase G-strand extension for length maintenance, establishing the two-step balance at the heart of telomere homeostasis.","evidence":"CTC1 disruption in human cells with overhang assays, RPA ChIP, and time-course telomere length measurement","pmids":["28334750"],"confidence":"High","gaps":["Did not identify the domain mediating telomerase termination","Coupling between fill-in and telomerase shutoff left mechanistically open"]},{"year":2017,"claim":"Extended CST function to ALT telomere maintenance, showing it localizes to APBs and restrains telomeric recombination.","evidence":"IF colocalization in ALT cells, CST knockdown, C-circle assay, telomere FISH","pmids":["28366536"],"confidence":"Medium","gaps":["Direct partners at APBs not identified","Single lab"]},{"year":2018,"claim":"Dissected the contributions of individual subunits and a central OB-fold, showing CTC1-STN1 is sufficient to terminate telomerase while TEN1 stabilizes ssDNA engagement for C-strand synthesis, and that pol α binding is required to fully repress telomerase.","evidence":"Crystal structure of CTC1 OB-fold; CRISPR knockouts of individual subunits; CRISPR knock-in of CTC1 L1142H; Co-IP, ssDNA binding, overhang and telomerase recruitment assays","pmids":["29228254","29774655","30026550"],"confidence":"High","gaps":["Full-length CST structure not determined","TPP1 not yet implicated as the termination partner"]},{"year":2018,"claim":"Revealed a non-telomeric genome-protection role, mapping a RAD51-interacting region of CTC1 that guards GC-rich fragile sites against replication-stress-induced breakage.","evidence":"CST-RAD51 Co-IP, RAD51 foci IF, chromosome breakage and fragile-site FISH across a disease mutation panel","pmids":["29481669"],"confidence":"Medium","gaps":["RAD51 interaction not reconstituted in vitro","Relationship to canonical HR recombination unclear"]},{"year":2020,"claim":"Showed CTC1 loss produces a local but not global ATR checkpoint, attributable to reduced TopBP1, refining how telomere-localized damage signals propagate.","evidence":"Conditional CTC1 knockout with phospho-CHK1/RPA/ATR immunoblot, TopBP1 levels, and ATR/CHK1/ATM inhibition epistasis","pmids":["33269665"],"confidence":"Medium","gaps":["Mechanism linking CTC1 loss to TopBP1 reduction unknown","Single lab"]},{"year":2023,"claim":"Identified the CTC1 OB-B domain–TPP1 interaction as the specific molecular switch for telomerase termination, cleanly separating this function from C-strand fill-in.","evidence":"CTC1 domain deletion and point mutant panel in CTC1-/- cells, CST-TPP1 Co-IP, telomerase ChIP, C-strand fill-in assays","pmids":["37021555"],"confidence":"High","gaps":["Structural basis of the CTC1-TPP1 interface not resolved","How TPP1 binding triggers telomerase release mechanistically unclear"]},{"year":2025,"claim":"Defined CST as a central 53BP1-axis effector at double-strand breaks that suppresses EXO1 and BLM-DNA2 resection to control repair pathway choice, linking CST mutants to PARP inhibitor resistance.","evidence":"Epistasis genetics, resection assays, CST DNA-binding and interaction mutants, in vitro resection reconstitution, PARP inhibitor sensitivity in BRCA1-deficient cells","pmids":["40403056"],"confidence":"High","gaps":["How CST is recruited to DSBs versus telomeres not distinguished","Stoichiometry with 53BP1 axis components unresolved"]},{"year":2025,"claim":"Established post-translational control of CTC1 abundance, showing STN1 protects CTC1 from TRIM32-mediated ubiquitination by competing at the OB-G cleft.","evidence":"Reciprocal Co-IP, ubiquitination and proteasome-rescue assays, AlphaFold3 modeling, proliferation assays","pmids":["40923710"],"confidence":"Medium","gaps":["TRIM32-CTC1 interface validated only by modeling and Co-IP","Physiological conditions regulating this competition unknown","Not independently replicated"]},{"year":null,"claim":"How CST is differentially targeted to telomeres, replication forks, ALT bodies, and DSBs—and how a single ssDNA-binding complex is partitioned among these functions—remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No full-length CST structure on substrate","Recruitment determinants distinguishing telomeric vs genome-wide roles unknown","Regulation of the resection-suppression versus fill-in functions not integrated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,4,11]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,2,9,13,14]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,11]}],"localization":[{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[0,3,8]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[4]}],"pathway":[{"term_id":"R-HSA-69306","term_label":"DNA Replication","supporting_discovery_ids":[1,2,3,6]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[10,14]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[3,12]}],"complexes":["CST complex (CTC1-STN1-TEN1)","alpha-accessory factor (AAF) complex"],"partners":["STN1","TEN1","TPP1","RAD51","TRIM32","EXO1","BLM"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q2NKJ3","full_name":"CST complex subunit CTC1","aliases":["Conserved telomere maintenance component 1","HBV DNAPTP1-transactivated protein B"],"length_aa":1217,"mass_kda":134.6,"function":"Component of the CST complex proposed to act as a specialized replication factor promoting DNA replication under conditions of replication stress or natural replication barriers such as the telomere duplex. The CST complex binds single-stranded DNA with high affinity in a sequence-independent manner, while isolated subunits bind DNA with low affinity by themselves. Initially the CST complex has been proposed to protect telomeres from DNA degradation (PubMed:19854130). However, the CST complex has been shown to be involved in several aspects of telomere replication. The CST complex inhibits telomerase and is involved in telomere length homeostasis; it is proposed to bind to newly telomerase-synthesized 3' overhangs and to terminate telomerase action implicating the association with the ACD:POT1 complex thus interfering with its telomerase stimulation activity. The CST complex is also proposed to be involved in fill-in synthesis of the telomeric C-strand probably implicating recruitment and activation of DNA polymerase alpha (PubMed:22763445). The CST complex facilitates recovery from many forms of exogenous DNA damage; seems to be involved in the re-initiation of DNA replication at repaired forks and/or dormant origins (PubMed:25483097). Involved in telomere maintenance (PubMed:19854131, PubMed:22863775). Involved in genome stability (PubMed:22863775). May be in involved in telomeric C-strand fill-in during late S/G2 phase (By similarity)","subcellular_location":"Nucleus; Chromosome, telomere","url":"https://www.uniprot.org/uniprotkb/Q2NKJ3/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CTC1","classification":"Not Classified","n_dependent_lines":480,"n_total_lines":1208,"dependency_fraction":0.3973509933774834},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"DDOST","stoichiometry":0.2},{"gene":"FKBP5","stoichiometry":0.2},{"gene":"STT3B","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/CTC1","total_profiled":1310},"omim":[{"mim_id":"620063","title":"DNA POLYMERASE ALPHA-2, ACCESSORY SUBUNIT; POLA2","url":"https://www.omim.org/entry/620063"},{"mim_id":"618030","title":"SHIELD COMPLEX, SUBUNIT 3; SHLD3","url":"https://www.omim.org/entry/618030"},{"mim_id":"618029","title":"SHIELD COMPLEX, SUBUNIT 2; SHLD2","url":"https://www.omim.org/entry/618029"},{"mim_id":"618028","title":"SHIELD COMPLEX, SUBUNIT 1; SHLD1","url":"https://www.omim.org/entry/618028"},{"mim_id":"614561","title":"LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS; LCC","url":"https://www.omim.org/entry/614561"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/CTC1"},"hgnc":{"alias_symbol":["FLJ22170","AAF132"],"prev_symbol":["C17orf68"]},"alphafold":{"accession":"Q2NKJ3","domains":[{"cath_id":"-","chopping":"12-188","consensus_level":"high","plddt":80.2136,"start":12,"end":188},{"cath_id":"2.40.50.140","chopping":"202-318","consensus_level":"high","plddt":81.4981,"start":202,"end":318},{"cath_id":"2.40.50.140","chopping":"351-489_502-516_524-542","consensus_level":"high","plddt":82.4971,"start":351,"end":542},{"cath_id":"-","chopping":"553-702","consensus_level":"high","plddt":86.6953,"start":553,"end":702},{"cath_id":"2.40.50","chopping":"729-749_759-779_794-867","consensus_level":"high","plddt":84.6512,"start":729,"end":867},{"cath_id":"2.40.50.140","chopping":"884-911_927-997","consensus_level":"high","plddt":78.0034,"start":884,"end":997},{"cath_id":"2.40.50","chopping":"1013-1204","consensus_level":"high","plddt":78.417,"start":1013,"end":1204}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q2NKJ3","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q2NKJ3-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q2NKJ3-F1-predicted_aligned_error_v6.png","plddt_mean":77.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CTC1","jax_strain_url":"https://www.jax.org/strain/search?query=CTC1"},"sequence":{"accession":"Q2NKJ3","fasta_url":"https://rest.uniprot.org/uniprotkb/Q2NKJ3.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q2NKJ3/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q2NKJ3"}},"corpus_meta":[{"pmid":"19854130","id":"PMC_19854130","title":"RPA-like mammalian Ctc1-Stn1-Ten1 complex binds to single-stranded DNA and protects telomeres independently of the Pot1 pathway.","date":"2009","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/19854130","citation_count":286,"is_preprint":false},{"pmid":"22267198","id":"PMC_22267198","title":"Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus.","date":"2012","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22267198","citation_count":228,"is_preprint":false},{"pmid":"23001564","id":"PMC_23001564","title":"Genome-wide meta-analysis points to CTC1 and ZNF676 as genes regulating telomere homeostasis in humans.","date":"2012","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23001564","citation_count":191,"is_preprint":false},{"pmid":"22387016","id":"PMC_22387016","title":"Mutations in CTC1, encoding the CTS telomere maintenance complex component 1, cause cerebroretinal microangiopathy with calcifications and cysts.","date":"2012","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22387016","citation_count":144,"is_preprint":false},{"pmid":"22531781","id":"PMC_22531781","title":"CTC1 deletion results in defective telomere replication, leading to catastrophic telomere loss and stem cell exhaustion.","date":"2012","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/22531781","citation_count":143,"is_preprint":false},{"pmid":"22532422","id":"PMC_22532422","title":"CTC1 Mutations in a patient with dyskeratosis congenita.","date":"2012","source":"Pediatric blood & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/22532422","citation_count":108,"is_preprint":false},{"pmid":"24115768","id":"PMC_24115768","title":"Molecular basis of telomere syndrome caused by CTC1 mutations.","date":"2013","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/24115768","citation_count":95,"is_preprint":false},{"pmid":"28334750","id":"PMC_28334750","title":"CTC1-mediated C-strand fill-in is an essential step in telomere length maintenance.","date":"2017","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/28334750","citation_count":81,"is_preprint":false},{"pmid":"23869908","id":"PMC_23869908","title":"Functional characterization of human CTC1 mutations reveals novel mechanisms responsible for the pathogenesis of the telomere disease Coats plus.","date":"2013","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/23869908","citation_count":64,"is_preprint":false},{"pmid":"30026550","id":"PMC_30026550","title":"CTC1-STN1 terminates telomerase while STN1-TEN1 enables C-strand synthesis during telomere replication in colon cancer cells.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30026550","citation_count":58,"is_preprint":false},{"pmid":"22086929","id":"PMC_22086929","title":"Xenopus laevis Ctc1-Stn1-Ten1 (xCST) protein complex is involved in priming DNA synthesis on single-stranded DNA template in Xenopus egg extract.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22086929","citation_count":57,"is_preprint":false},{"pmid":"29774655","id":"PMC_29774655","title":"CTC1-STN1 coordinates G- and C-strand synthesis to regulate telomere length.","date":"2018","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/29774655","citation_count":43,"is_preprint":false},{"pmid":"29481669","id":"PMC_29481669","title":"Pathogenic CTC1 mutations cause global genome instabilities under replication stress.","date":"2018","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/29481669","citation_count":38,"is_preprint":false},{"pmid":"28366536","id":"PMC_28366536","title":"The human CTC1/STN1/TEN1 complex regulates telomere maintenance in ALT cancer cells.","date":"2017","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/28366536","citation_count":34,"is_preprint":false},{"pmid":"30393977","id":"PMC_30393977","title":"CTC1 mutations in a Brazilian family with progeroid features and recurrent bone fractures.","date":"2018","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30393977","citation_count":26,"is_preprint":false},{"pmid":"24718655","id":"PMC_24718655","title":"CTC1 increases the radioresistance of human melanoma cells by inhibiting telomere shortening and apoptosis.","date":"2014","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24718655","citation_count":25,"is_preprint":false},{"pmid":"32543263","id":"PMC_32543263","title":"A unique case of coats plus syndrome and dyskeratosis congenita in a patient with CTC1 mutations.","date":"2020","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32543263","citation_count":25,"is_preprint":false},{"pmid":"29228254","id":"PMC_29228254","title":"Structural and functional analysis of an OB-fold in human Ctc1 implicated in telomere maintenance and bone marrow syndromes.","date":"2018","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/29228254","citation_count":19,"is_preprint":false},{"pmid":"25928698","id":"PMC_25928698","title":"Whole exome sequencing in an Indian family links Coats plus syndrome and dextrocardia with a homozygous novel CTC1 and a rare HES7 variation.","date":"2015","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25928698","citation_count":19,"is_preprint":false},{"pmid":"25843205","id":"PMC_25843205","title":"Cerebro-retinal microangiopathy with calcifications and cysts due to recessive mutations in the CTC1 gene.","date":"2015","source":"Revue neurologique","url":"https://pubmed.ncbi.nlm.nih.gov/25843205","citation_count":18,"is_preprint":false},{"pmid":"33269665","id":"PMC_33269665","title":"Human CTC1 promotes TopBP1 stability and CHK1 phosphorylation in response to telomere dysfunction and global replication stress.","date":"2020","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/33269665","citation_count":17,"is_preprint":false},{"pmid":"30891747","id":"PMC_30891747","title":"Impact of germline CTC1 alterations on telomere length in acquired bone marrow failure.","date":"2019","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/30891747","citation_count":15,"is_preprint":false},{"pmid":"29111009","id":"PMC_29111009","title":"Novel biallelic missense mutations in CTC1 gene identified in a Chinese family with Coats plus syndrome.","date":"2017","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29111009","citation_count":14,"is_preprint":false},{"pmid":"37021555","id":"PMC_37021555","title":"CTC1 OB-B interaction with TPP1 terminates telomerase and prevents telomere overextension.","date":"2023","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/37021555","citation_count":13,"is_preprint":false},{"pmid":"35368664","id":"PMC_35368664","title":"Pan-Cancer Analyses Identify the CTC1-STN1-TEN1 Complex as a Protective Factor and Predictive Biomarker for Immune Checkpoint Blockade in Cancer.","date":"2022","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35368664","citation_count":13,"is_preprint":false},{"pmid":"35134616","id":"PMC_35134616","title":"Pan-cancer analysis reveals that CTC1-STN1-TEN1 (CST) complex may have a key position in oncology.","date":"2022","source":"Cancer genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35134616","citation_count":11,"is_preprint":false},{"pmid":"40403056","id":"PMC_40403056","title":"CTC1-STN1-TEN1 controls DNA break repair pathway choice via DNA end resection blockade.","date":"2025","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/40403056","citation_count":10,"is_preprint":false},{"pmid":"23220793","id":"PMC_23220793","title":"Cerebroretinal microangiopathy with calcifications and cysts associated with CTC1 and NDP mutations.","date":"2012","source":"Journal of child neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23220793","citation_count":10,"is_preprint":false},{"pmid":"34706368","id":"PMC_34706368","title":"Primary Ovarian Failure in Addition to Classical Clinical Features of Coats Plus Syndrome in a Female Carrying 2 Truncating Variants of CTC1.","date":"2021","source":"Hormone research in paediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/34706368","citation_count":8,"is_preprint":false},{"pmid":"33034244","id":"PMC_33034244","title":"Ophthalmic findings and a novel CTC1 gene mutation in coats plus syndrome: a case report.","date":"2020","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33034244","citation_count":7,"is_preprint":false},{"pmid":"37978541","id":"PMC_37978541","title":"A novel mutation of CTC1 leads to telomere shortening in a chinese family with interstitial lung disease.","date":"2023","source":"Hereditas","url":"https://pubmed.ncbi.nlm.nih.gov/37978541","citation_count":7,"is_preprint":false},{"pmid":"33937245","id":"PMC_33937245","title":"miR-376a Provokes Rectum Adenocarcinoma Via CTC1 Depletion-Induced Telomere Dysfunction.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/33937245","citation_count":4,"is_preprint":false},{"pmid":"37404458","id":"PMC_37404458","title":"Germline variant of CTC1 gene in a patient with pulmonary fibrosis and myelodysplastic syndrome.","date":"2023","source":"Multidisciplinary respiratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37404458","citation_count":3,"is_preprint":false},{"pmid":"36761951","id":"PMC_36761951","title":"Case Report: CTC1 mutations in a patient with diffuse hepatic and splenic hemangiomatosis complicated by Kasabach-Merritt syndrome.","date":"2023","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36761951","citation_count":3,"is_preprint":false},{"pmid":"39001931","id":"PMC_39001931","title":"Suppression of CTC1 inhibits hepatocellular carcinoma cell growth and enhances RHPS4 cytotoxicity.","date":"2024","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/39001931","citation_count":2,"is_preprint":false},{"pmid":"41036624","id":"PMC_41036624","title":"KRAS-induced STN1 (OBFC1) promotes proper CTC1-STN1-TEN1 complex-independent DNA double-strand break repair and cell cycle checkpoint maintenance in pancreatic cancer.","date":"2025","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/41036624","citation_count":2,"is_preprint":false},{"pmid":"25274733","id":"PMC_25274733","title":"Telomere stability and development of ctc1 mutants are rescued by inhibition of EJ recombination pathways in a telomerase-dependent manner.","date":"2014","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/25274733","citation_count":2,"is_preprint":false},{"pmid":"27265469","id":"PMC_27265469","title":"Downregulation of SWI5 and CTC1 genes: hepatitis B virus DNA polymerase transactivated protein 1-mediated inhibition of DNA repair.","date":"2016","source":"Acta virologica","url":"https://pubmed.ncbi.nlm.nih.gov/27265469","citation_count":2,"is_preprint":false},{"pmid":"36233645","id":"PMC_36233645","title":"Transcriptomic Analysis of Conserved Telomere Maintenance Component 1 (CTC1) and Its Association with Leukemia.","date":"2022","source":"Journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36233645","citation_count":1,"is_preprint":false},{"pmid":"40923710","id":"PMC_40923710","title":"STN1 Shields CTC1 From TRIM32-Mediated Ubiquitination to Prevent Cellular Aging.","date":"2025","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/40923710","citation_count":0,"is_preprint":false},{"pmid":"38540151","id":"PMC_38540151","title":"Associations between ZNF676, CTC1 Gene Polymorphisms and Relative Leukocyte Telomere Length with Myopia and Its Degree.","date":"2024","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/38540151","citation_count":0,"is_preprint":false},{"pmid":"41554616","id":"PMC_41554616","title":"CTC1 mutation causing cerebro-retinal microangiopathy with calcifications and cysts type 1, masquerading as TORCH Infection.","date":"2026","source":"BMJ case reports","url":"https://pubmed.ncbi.nlm.nih.gov/41554616","citation_count":0,"is_preprint":false},{"pmid":"41575730","id":"PMC_41575730","title":"Preimplantation genetic testing-M for pathogenic variant in CTC1 gene causing cerebroretinal microangiopathy.","date":"2026","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/41575730","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.08.06.669015","title":"Conditional deletion of human STN1 leads to telomere dysfunction and telomerase-dependent genome instability and proliferation defects","date":"2025-08-07","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.06.669015","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.09.22.677761","title":"Distinct ATRX functions cooperate with 9-1-1 and CST complexes to safeguard replication and telomere integrity","date":"2025-09-22","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.22.677761","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.07.08.25331123","title":"Telomere Biology Disorder Predisposition in Bone Marrow Failure and Clonal Hematopoiesis","date":"2025-07-08","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.08.25331123","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.06.04.657974","title":"In vivo investigation of STN1 downregulation in melanoma formation in adult mice following UV irradiation","date":"2025-06-07","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.04.657974","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.08.06.606774","title":"Dysfunction of telomeric Cdc13-Stn1-Ten1 simultaneously activates the DNA damage and spindle checkpoints","date":"2024-08-06","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.06.606774","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":23655,"output_tokens":4404,"usd":0.068513,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":12434,"output_tokens":4353,"usd":0.085498,"stage2_stop_reason":"end_turn"},"total_usd":0.154011,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2009,\n      \"finding\": \"Mammalian CTC1 forms an RPA-like trimeric complex with STN1 and TEN1 (CST complex) that binds single-stranded DNA with high affinity in a sequence-independent manner and associates with a fraction of telomeres throughout the cell cycle. STN1 knockdown caused significant increases in single-stranded G-strand telomeric DNA, indicating a role in DNA metabolism at telomeres.\",\n      \"method\": \"Protein isolation, ssDNA binding assays, immunofluorescence/colocalization, knockdown with telomere analysis\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal characterization with multiple orthogonal methods (ssDNA binding, cell fractionation, IF colocalization, knockdown phenotype); foundational study replicated by multiple subsequent labs\",\n      \"pmids\": [\"19854130\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Xenopus CST (xCST) complex is involved in priming DNA synthesis on single-stranded DNA templates via regulation of DNA polymerase α-primase; immunodepletion of xStn1 blocked DNA synthesis on ssDNA template but not on pre-primed ssDNA, indicating CST acts at the priming step.\",\n      \"method\": \"Xenopus egg extract reconstitution, immunodepletion of xStn1, in vitro DNA replication assay on ssDNA templates\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution in Xenopus egg extract with immunodepletion and primed vs unprimed ssDNA controls, single lab but multiple orthogonal experiments\",\n      \"pmids\": [\"22086929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CTC1 is a subunit of the α-accessory factor (AAF) complex that stimulates the activity of DNA polymerase-α primase. CTC1 mutations in Coats plus patients result in shortened telomeres and increased spontaneous γH2AX-positive cells.\",\n      \"method\": \"Patient mutation analysis, telomere length measurement, γH2AX immunostaining in patient-derived cell lines\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional cellular readouts in patient-derived lines with two orthogonal methods, single study\",\n      \"pmids\": [\"22267198\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Conditional deletion of CTC1 in mice leads to ATR-dependent G2/M checkpoint activation, global cellular proliferative defects, bone marrow failure, and catastrophic telomere loss. CTC1 facilitates telomere replication by promoting efficient restart of stalled replication forks, and its deletion causes increased loss of leading C-strand telomeres and accumulation of excessive ssDNA telomere sequences. CTC1 is not required for telomere capping.\",\n      \"method\": \"Conditional mouse knockout (Cre-lox), flow cytometry, telomere FISH, BrdU incorporation, ATR pathway analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean conditional KO in mice with multiple orthogonal readouts (proliferation, checkpoint activation, telomere structure); findings consistent with subsequent independent studies\",\n      \"pmids\": [\"22531781\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Disease mutations in CTC1 disrupt: (1) CST complex formation with STN1/TEN1; (2) physical interaction with DNA polymerase α-primase; (3) telomeric ssDNA binding in vitro; (4) nuclear accumulation; and/or (5) telomere association in vivo. All mutations commonly lead to accumulation of internal single-stranded gaps of telomeric DNA, indicating telomere DNA replication defects. Some CTC1 mutations also unleash telomerase repression and telomere length control.\",\n      \"method\": \"Co-immunoprecipitation, in vitro ssDNA binding assays, immunofluorescence, telomere FISH, active-site/disease mutation analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal biochemical and cell biological methods in a single focused study; findings replicated by independent groups\",\n      \"pmids\": [\"24115768\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CTC1 frameshift mutations generate truncated or unstable protein products that cannot form a complex with STN1-TEN1 at telomeres, resulting in progressive telomere shortening and chromosome fusions. CTC1 missense mutations can form the CST complex at telomeres but may be repressed by frameshift mutants. CTC1 mutations promote telomere dysfunction by decreasing STN1 stability and reducing STN1's ability to interact with DNA Pol-α.\",\n      \"method\": \"Biochemical characterization of mutant proteins, Co-IP, telomere FISH, chromosomal fusion analysis in human cells\",\n      \"journal\": \"Aging cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical assays in a single lab with disease mutation panel; partially replicated by Chen et al. 2013\",\n      \"pmids\": [\"23869908\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Disruption of CTC1 in human cells results in elongation of the 3′ G-strand overhang, accumulation of RPA at telomeres, and telomeric DNA damage signaling. C-strand length decreases continuously following CTC1 disruption while G-strand initially grows (due to telomerase), indicating CST-mediated C-strand fill-in is essential for telomere length maintenance and that telomerase-mediated G-strand extension and CST-mediated C-strand fill-in are equally important.\",\n      \"method\": \"CTC1 disruption in human cells, telomere overhang assays, RPA ChIP, telomere length measurement over time\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean CTC1 disruption with multiple independent telomere structural readouts; findings replicated across multiple groups\",\n      \"pmids\": [\"28334750\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Human CST complex localizes to ALT-associated PML bodies (APBs) in ALT cancer cells. CST suppression in ALT cells induces telomere fragility, elevated telomeric DNA recombination, reduces C-circle and t-circle abundance, and causes multinucleation.\",\n      \"method\": \"IF colocalization in ALT cells, CST knockdown, C-circle assay, telomere FISH\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiments linked to functional consequences, multiple readouts, single lab\",\n      \"pmids\": [\"28366536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Crystal structure of a central OB-fold domain of human CTC1 was determined. This domain does not directly contribute to substrate binding but affects full-length CTC1 localization to telomeres and STN1-TEN1 binding. Disease mutations R840W and V871M contribute to the fold of this domain. Deletion of this OB-fold domain leads to increased telomere length, frequency of internal single G-strands, and fragile telomeres.\",\n      \"method\": \"X-ray crystallography, in vitro binding assays, site-directed mutagenesis, telomere localization assays, telomere FISH\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure with mutagenesis validation and functional telomere assays, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"29228254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CTC1-STN1 interaction is required to repress telomerase activity. CTC1^L1142H mutation impairs CTC1-STN1 interaction, leading to telomerase-mediated telomere elongation. Impaired CTC1^L1142H:STN1 interaction with DNA Pol-α results in increased telomerase recruitment and further telomere elongation. CST binding to DNA Pol-α is required to fully repress telomerase activity. CST mutants that fail to interact with DNA Pol-α result in loss of C-strand maintenance and catastrophic telomere shortening.\",\n      \"method\": \"CRISPR/Cas9 knock-in of disease mutation, Co-IP, telomere length analysis, telomerase recruitment assay\",\n      \"journal\": \"Aging cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — CRISPR knock-in with multiple biochemical and functional readouts, mechanistically dissecting G-strand vs C-strand regulation; consistent with independent studies\",\n      \"pmids\": [\"29774655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Pathogenic CTC1 missense and small deletion mutations induce spontaneous chromosome breakage and severe chromosome fragmentation elevated by replication stress, leading to global genome instabilities. These mutations abolish or reduce CST interaction with RAD51, disrupt RAD51 foci formation, and/or diminish binding to GC-rich genomic fragile sites. The aa 600-989 region of CTC1 contains a RAD51-interacting domain.\",\n      \"method\": \"Co-IP (CST-RAD51), RAD51 foci immunofluorescence, chromosome breakage analysis, fragile site FISH, disease mutation panel\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple mutant panel with Co-IP and chromosomal readouts, single lab, two orthogonal methods\",\n      \"pmids\": [\"29481669\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CTC1-STN1 limits telomerase action to prevent G-overhang overextension. CTC1-/- cells exhibit telomeric DNA damage and growth arrest due to overhang elongation. CTC1-STN1 retains ssDNA binding affinity but TEN1 stabilizes binding. CTC1-STN1 binding is sufficient to terminate telomerase action, but without TEN1 it cannot properly engage DNA polymerase α on the overhang for C-strand synthesis.\",\n      \"method\": \"CRISPR knockout of individual CST subunits (CTC1, TEN1), ssDNA binding assays, telomere overhang analysis, cell proliferation assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — individual subunit knockouts with biochemical and functional dissection; distinguishes CTC1-STN1 vs TEN1 roles with multiple readouts\",\n      \"pmids\": [\"30026550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CTC1 knockout inhibits CHK1 phosphorylation following hydroxyurea-induced replication stress by causing decreased levels of the ATR activator TopBP1. CTC1 KO activates ATR locally at telomeres (leading to RPA and ATR autophosphorylation) but does not elicit a global checkpoint response through CHK1. ATR but not CHK1 or ATM is required for G2 arrest and RPA phosphorylation following CTC1 removal.\",\n      \"method\": \"Conditional CTC1 knockout, phospho-CHK1/RPA/ATR immunoblot, TopBP1 protein level analysis, ATR/CHK1/ATM inhibition epistasis\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with epistasis analysis and multiple signaling readouts, single lab\",\n      \"pmids\": [\"33269665\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CTC1 OB-B domain is a key determinant of telomerase termination but not C-strand synthesis. CTC1-ΔB expression rescues C-strand fill-in and prevents telomeric DNA damage but causes progressive telomere elongation and accumulation of telomerase at telomeres. CTC1 OB-B domain mediates interaction with TPP1, and this CTC1-TPP1 interaction plays a key role in telomerase termination. OB-B point mutations weakening TPP1 association track with inability to limit telomerase action.\",\n      \"method\": \"CTC1 domain deletion/point mutant panel in CTC1-/- cells, Co-IP (CST-TPP1), telomere length analysis, telomerase ChIP, C-strand fill-in assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — structure-function dissection with multiple CTC1 mutants, reciprocal Co-IP, and functional rescue experiments; mechanistically comprehensive single study\",\n      \"pmids\": [\"37021555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"The CST complex suppresses DNA end resection by EXO1 and the BLM-DNA2 helicase-nuclease complex, controlling DSB repair pathway choice between end joining and homologous recombination. CST acts as a central 53BP1 axis component. BRCA1-BARD1 alleviates CST-imposed EXO1 blockade but has little effect on BLM-DNA2 restriction. CST mutants impaired for DNA binding or BLM-EXO1 interaction exhibit hyper-resection and render BRCA1-deficient cells resistant to PARP inhibitors.\",\n      \"method\": \"Epistasis genetics, resection assays, CST DNA-binding and protein interaction mutants, PARP inhibitor sensitivity in BRCA1-deficient cells, in vitro reconstitution of end resection\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — mechanistic dissection with multiple mutants, epistasis with BRCA1-BARD1, in vitro and in vivo resection assays, published in Science\",\n      \"pmids\": [\"40403056\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"STN1 directly interacts with CTC1 and stabilizes CTC1 by preventing its TRIM32-mediated ubiquitination and proteasomal degradation. TRIM32 interacts with the OB-G domain of CTC1 near the STN1-interacting 'cleft' motif, and STN1 binding to this region competes with TRIM32 to protect CTC1 from degradation. TRIM32 and the CTC1/STN1 complex exert opposing effects on cellular proliferation.\",\n      \"method\": \"Co-IP (STN1-CTC1, TRIM32-CTC1), ubiquitination assays, proteasome inhibitor rescue, AlphaFold3 structural modeling, knockdown/overexpression proliferation assays\",\n      \"journal\": \"Aging cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP with functional ubiquitination assays and structural modeling; single lab, novel finding not yet replicated\",\n      \"pmids\": [\"40923710\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CTC1 forms the heterotrimeric RPA-like CST complex (CTC1-STN1-TEN1) that binds ssDNA and functions at telomeres by: (1) promoting C-strand fill-in synthesis via stimulation of DNA polymerase α-primase; (2) terminating telomerase-mediated G-strand extension through its OB-B domain interaction with TPP1; (3) restarting stalled replication forks at telomeres; (4) suppressing DNA end resection at DSBs as a 53BP1 axis component to control repair pathway choice; CTC1 is stabilized by direct STN1 interaction which competes with TRIM32-mediated ubiquitination, and disease mutations in CTC1 disrupt complex formation, DNA pol-α interaction, ssDNA binding, nuclear localization, and/or telomere association, collectively causing telomere replication defects and global genome instability.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CTC1 is the largest subunit of the heterotrimeric, RPA-like CST complex (CTC1-STN1-TEN1) that binds single-stranded DNA with high, sequence-independent affinity and acts at telomeres to coordinate the completion of replication and the regulation of telomerase [#0, #11]. Mechanistically, CST stimulates DNA polymerase α-primase to prime and fill in the telomeric C-strand: it functions at the priming step on ssDNA templates [#1], operates as the α-accessory factor that stimulates pol α-primase activity [#2], and promotes restart of stalled replication forks during telomere replication, with loss causing C-strand depletion, excess G-strand ssDNA, ATR-dependent checkpoint activation, and catastrophic telomere loss [#3, #6]. CST balances this fill-in activity against telomerase: CTC1-STN1 binding terminates telomerase-mediated G-strand extension and prevents overhang overextension, while the CTC1 OB-B domain mediates a TPP1 interaction that is the key determinant of telomerase termination, separable from its C-strand synthesis role [#11, #13]. Beyond telomeres, CST acts as a central component of the 53BP1 axis at double-strand breaks, suppressing EXO1- and BLM-DNA2-mediated end resection to govern repair pathway choice, with BRCA1-BARD1 relieving the CST-imposed EXO1 blockade [#14]. CST also localizes to ALT-associated PML bodies and restrains telomeric recombination in ALT cancer cells [#7], and CTC1 interacts with RAD51 to protect GC-rich genomic fragile sites against replication-stress-induced breakage [#10]. CTC1 stability is set by STN1, which binds near the OB-G cleft and competes with TRIM32-mediated ubiquitination and proteasomal degradation [#15]. Pathogenic CTC1 mutations in Coats plus disrupt CST assembly, pol α-primase interaction, ssDNA binding, nuclear accumulation, and/or telomere association, producing internal telomeric ssDNA gaps, telomere shortening, chromosome fusions, and global genome instability [#2, #4, #5].\",\n  \"teleology\": [\n    {\n      \"year\": 2009,\n      \"claim\": \"Established that mammalian CTC1 is not a standalone factor but a subunit of an RPA-like ssDNA-binding trimer (CST) acting at telomeres, defining the molecular entity to be studied.\",\n      \"evidence\": \"Protein isolation, ssDNA binding assays, IF colocalization, and STN1 knockdown with telomere analysis\",\n      \"pmids\": [\"19854130\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define which enzymatic step CST controls\", \"Fraction of telomeres bound and cell-cycle dependence not mechanistically explained\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Placed CST at the priming step of DNA synthesis, showing it regulates DNA pol α-primase rather than elongation, the first mechanistic assignment of a catalytic function.\",\n      \"evidence\": \"Xenopus egg extract reconstitution with xStn1 immunodepletion and primed vs unprimed ssDNA controls\",\n      \"pmids\": [\"22086929\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Done in Xenopus extract, not human reconstitution\", \"Direct physical contact between CTC1 and pol α not mapped here\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Connected CTC1 to human disease and to pol α-primase stimulation, showing loss-of-function causes telomere shortening and DNA damage in patients.\",\n      \"evidence\": \"Coats plus patient mutation analysis, telomere length and γH2AX immunostaining in patient cells; biochemical identification as α-accessory factor\",\n      \"pmids\": [\"22267198\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single study\", \"Did not separate replication defect from telomerase dysregulation\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined CTC1's in vivo role as facilitating telomere replication via stalled fork restart, distinct from telomere capping, and linked its loss to ATR checkpoint and bone marrow failure.\",\n      \"evidence\": \"Conditional mouse knockout with telomere FISH, BrdU incorporation, flow cytometry, ATR pathway analysis\",\n      \"pmids\": [\"22531781\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of fork restart not biochemically reconstituted\", \"Relationship between leading C-strand loss and pol α stimulation not resolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Resolved how disease mutations act by mapping them to discrete molecular defects—complex assembly, pol α binding, ssDNA binding, nuclear localization, telomere association—unifying genotype with telomere replication failure.\",\n      \"evidence\": \"Co-IP, in vitro ssDNA binding, IF, telomere FISH across disease and active-site mutation panels in human cells\",\n      \"pmids\": [\"24115768\", \"23869908\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Some mutations had pleiotropic effects, complicating one-to-one defect assignment\", \"STN1 stability effects characterized only in part\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrated that CST-mediated C-strand fill-in is as essential as telomerase G-strand extension for length maintenance, establishing the two-step balance at the heart of telomere homeostasis.\",\n      \"evidence\": \"CTC1 disruption in human cells with overhang assays, RPA ChIP, and time-course telomere length measurement\",\n      \"pmids\": [\"28334750\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the domain mediating telomerase termination\", \"Coupling between fill-in and telomerase shutoff left mechanistically open\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Extended CST function to ALT telomere maintenance, showing it localizes to APBs and restrains telomeric recombination.\",\n      \"evidence\": \"IF colocalization in ALT cells, CST knockdown, C-circle assay, telomere FISH\",\n      \"pmids\": [\"28366536\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct partners at APBs not identified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Dissected the contributions of individual subunits and a central OB-fold, showing CTC1-STN1 is sufficient to terminate telomerase while TEN1 stabilizes ssDNA engagement for C-strand synthesis, and that pol α binding is required to fully repress telomerase.\",\n      \"evidence\": \"Crystal structure of CTC1 OB-fold; CRISPR knockouts of individual subunits; CRISPR knock-in of CTC1 L1142H; Co-IP, ssDNA binding, overhang and telomerase recruitment assays\",\n      \"pmids\": [\"29228254\", \"29774655\", \"30026550\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length CST structure not determined\", \"TPP1 not yet implicated as the termination partner\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Revealed a non-telomeric genome-protection role, mapping a RAD51-interacting region of CTC1 that guards GC-rich fragile sites against replication-stress-induced breakage.\",\n      \"evidence\": \"CST-RAD51 Co-IP, RAD51 foci IF, chromosome breakage and fragile-site FISH across a disease mutation panel\",\n      \"pmids\": [\"29481669\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"RAD51 interaction not reconstituted in vitro\", \"Relationship to canonical HR recombination unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed CTC1 loss produces a local but not global ATR checkpoint, attributable to reduced TopBP1, refining how telomere-localized damage signals propagate.\",\n      \"evidence\": \"Conditional CTC1 knockout with phospho-CHK1/RPA/ATR immunoblot, TopBP1 levels, and ATR/CHK1/ATM inhibition epistasis\",\n      \"pmids\": [\"33269665\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking CTC1 loss to TopBP1 reduction unknown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified the CTC1 OB-B domain–TPP1 interaction as the specific molecular switch for telomerase termination, cleanly separating this function from C-strand fill-in.\",\n      \"evidence\": \"CTC1 domain deletion and point mutant panel in CTC1-/- cells, CST-TPP1 Co-IP, telomerase ChIP, C-strand fill-in assays\",\n      \"pmids\": [\"37021555\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the CTC1-TPP1 interface not resolved\", \"How TPP1 binding triggers telomerase release mechanistically unclear\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Defined CST as a central 53BP1-axis effector at double-strand breaks that suppresses EXO1 and BLM-DNA2 resection to control repair pathway choice, linking CST mutants to PARP inhibitor resistance.\",\n      \"evidence\": \"Epistasis genetics, resection assays, CST DNA-binding and interaction mutants, in vitro resection reconstitution, PARP inhibitor sensitivity in BRCA1-deficient cells\",\n      \"pmids\": [\"40403056\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How CST is recruited to DSBs versus telomeres not distinguished\", \"Stoichiometry with 53BP1 axis components unresolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Established post-translational control of CTC1 abundance, showing STN1 protects CTC1 from TRIM32-mediated ubiquitination by competing at the OB-G cleft.\",\n      \"evidence\": \"Reciprocal Co-IP, ubiquitination and proteasome-rescue assays, AlphaFold3 modeling, proliferation assays\",\n      \"pmids\": [\"40923710\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"TRIM32-CTC1 interface validated only by modeling and Co-IP\", \"Physiological conditions regulating this competition unknown\", \"Not independently replicated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How CST is differentially targeted to telomeres, replication forks, ALT bodies, and DSBs—and how a single ssDNA-binding complex is partitioned among these functions—remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No full-length CST structure on substrate\", \"Recruitment determinants distinguishing telomeric vs genome-wide roles unknown\", \"Regulation of the resection-suppression versus fill-in functions not integrated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 4, 11]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 2, 9, 13, 14]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 11]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [0, 3, 8]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [1, 2, 3, 6]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [10, 14]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [3, 12]}\n    ],\n    \"complexes\": [\"CST complex (CTC1-STN1-TEN1)\", \"alpha-accessory factor (AAF) complex\"],\n    \"partners\": [\"STN1\", \"TEN1\", \"TPP1\", \"RAD51\", \"TRIM32\", \"EXO1\", \"BLM\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":7,"faith_pct":85.71428571428571}}